Company news
MapLight Therapeutics, Inc. news in 2026
MapLight Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.
MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
November 16, 2026
MapLight Therapeutics to Participate in Upcoming Investor Conference
November 9, 2026
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
October 6, 2026
MapLight Therapeutics to Participate in Upcoming Investor Conference
September 9, 2026
MapLight Therapeutics Announces $150 Million Private Placement Financing
August 13, 2026
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
July 27, 2026
MapLight Therapeutics Announces Changes to Board of Directors
June 24, 2026
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
June 21, 2026
MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
May 1, 2026
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 25, 2026
MapLight Therapeutics to Participate in Upcoming Investor Conferences
March 1, 2026
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
January 9, 2026
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
January 5, 2026
Decks in 2026
- Investor Presentation (November 2026)
Investor deck · 28 slides · Nov 16, 2026
- Investor Presentation (August 2026)
Investor deck · 28 slides · Aug 13, 2026
- Technical Presentation (July 2026)
Technical · 27 slides · Jul 27, 2026
- Technical Presentation (June 2026)
Technical · 21 slides · Jun 22, 2026
- Investor Presentation (May 2026)
Investor deck · 34 slides · May 14, 2026
- Investor Presentation (March 2026)
Investor deck · 34 slides · Mar 26, 2026
- Investor Presentation (January 2026)
Investor deck · 34 slides · Jan 9, 2026